Will regulatory issues continue to be a major barrier to access to bedaquiline and delamanid?-Reference-Cited by-同舟云学术

Will regulatory issues continue to be a major barrier to access to bedaquiline and delamanid?

Published:2018-03 Issue:3 Volume:51 Page:1702480
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Masini Tiziana,Hauser Janika,Kuwana Rutendo,Nhat Linh Nguyen,Jaramillo Ernesto

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference29 articles.

1. World Health Organization (WHO). Global Tuberculosis Report 2017. (WHO/HTM/TB/2017.23). Geneva, WHO, 2017. www.who.int/tb/publications/global_report/en/ Last updated: October, 2017. Date last accessed: January 10, 2018.

2. World Health Organization (WHO). Proposal for updating the definition of “stringent regulatory authority”. Geneva, WHO, 2017. http://www.who.int/medicines/areas/quality_safety/quality_assurance/SRA_QAS17-728Rev1_31082017.pdf Last updated: August, 2017. Date last accessed: January 10, 2018.

3. FDA News Release. https://wayback.archive-it.org/7993/20170112023916/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm Date last updated: December 31, 2012. Date last accessed: January 10, 2018.

4. European Medicines Agency. Deltyba. www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002552/smops/Positive/human_smop_000572.jsp&mid=WC0b01ac058001d127 Date last updated: November 21, 2013. Date last accessed: January 10, 2018.

5. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric multi-drug-resistant tuberculosis in Germany – diagnostic and therapeutic challenges of an “orphan disease”;European Journal of Pediatrics;2023-09-14

2. Liquid chromatography-tandem mass spectrometry analysis of delamanid and its metabolite in human cerebrospinal fluid using protein precipitation and on-line solid-phase extraction;Journal of Pharmaceutical and Biomedical Analysis;2023-04

3. Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis: insights from a qualitative study;BMC Infectious Diseases;2022-11-22

4. Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis - insights from a qualitative study;2022-09-23

5. An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study);American Journal of Respiratory and Critical Care Medicine;2022-05-15